Table 2.

Univariable and multivariable hazard ratios of MACE in patients with psoriasis compared with the general population

	Univariable			Multivariable
	Hazard ratio	95% CI	p-value	Hazard ratio	95% CI	p-value
Duration of psoriasis	1.039	1.036–1.042	<0.0001	1.010	1.007–1.013	<0.0001
Age	1.087	1.087–1.087	<0.0001	1.075	1.075–1.076	<0.0001
Male sex	1.230	1.218–1.242	<0.0001	1.516	1.501–1.532	<0.0001
Socio-economic status
0 (lowest)	1.722	1.695–1.748	<0.0001	1.118	1.101–1.136	<0.0001
1 (below average)	2.355	2.321–2.389	<0.0001	1.113	1.096–1.130	<0.0001
2 (average)	(reference)			(reference)
3 (above average)	0.536	0.526–0.547	<0.0001	0.855	0.838–0.873	<0.0001
4 (highest)	0.478	0.468–0.488	<0.0001	0.744	0.729–0.760	<0.0001
Previous CVD	8.667	8.581–8.755	<0.0001	2.278	2.252–2.305	<0.0001
Statin use	3.594	3.556–3.631	<0.0001	0.908	0.897–0.919	<0.0001
Diabetes	3.743	3.692–3.795	<0.0001	1.420	1.399–1.441	<0.0001
Hypertension	5.721	5.665–5.778	<0.0001	1.394	1.379–1.411	<0.0001
Alcohol abuse	1.612	1.565–1.659	<0.0001	1.905	1.850–1.961	<0.0001
Smoking	2.654	2.620–2.689	<0.0001	1.697	1.676–1.720	<0.0001

CVD, cardiovascular disease; CI, confidence interval